Is a complete AVNS research report available?

No complete published report is available for Avanos Medical, Inc. (AVNS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Avanos Medical, Inc. (AVNS)

NYSE: AVNS · USD

$25.0

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-28 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AVNS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.2B
Revenue (ttm)	715.9M
Net income (ttm)	-74.4M
EPS (ttm)	-$1.60
Shares out	46.8M
P/E (forward)	21.7x
Beta	1.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 715.9M
Net income (ttm): -74.4M
EPS (ttm): -$1.60
P/E (forward): 21.7x
Market cap: 1.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AVNS indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001606498
Company name	Avanos Medical, Inc.
Country	United States
Country code	US
Cusip	05350V106
Employees	2,287
Employees Change	60%
Employees Change Percent	2.69
Enterprise value	$1.2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.89
Industry PE Fwd	18.9
Isin	US05350V1061
Last refreshed	2026-07-28
Market cap	$1.2B
Market cap category	Small-Cap
Price	$24.99
Price currency	USD
Rev Per Employee	313,030.17x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.87
Sic	3842
Symbol	AVNS
Website	https://avanos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.36%
EV Sales Forward	1.74x
EV/FCF	165.8x
EV/Sales	1.74x
FCF yield	0.64%
Forward P/E	21.73x
P/B ratio	1.49x
P/S ratio	1.64x
PS Forward	1.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10.41%
EBITDA Margin	-4.89%
FCF margin	1.05%
Gross margin	50.05%
Gross Profit	$358.3M
Gross Profit Growth	-4.78%
Gross Profit Growth Q	4.9%
Gross Profit Growth3 Y	-3.29%
Gross Profit Growth5 Y	-0.4%
Net Income	$-74.4M
Net Income Growth Q	-22.73%
Net Income Growth Years	1%
Pretax Margin	-9.54%
Profit Margin	-10.39%
Profit Per Employee	$-32,532
Profitable Quarters	$1
ROA	0.95
Roa5y	0.88
ROCE	-8.11
ROE	-9.18
Roe5y	-9.61
ROIC	1.96
Roic5y	1.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.9%
Cagr1y	106.46%
Cagr3y	-0.29%
Cagr5y	-6.38%
EPS Growth Q	-21.66
EPS Growth Years	1
FCF Growth	-93.42%
FCF Growth3 Y	-51.06%
OCF Growth	-72.69%
OCF Growth10 Y	-9.57%
OCF Growth3 Y	-23.6%
Revenue Growth	3.87x
Revenue Growth Q	8.78x
Revenue Growth Quarters	6x
Revenue Growth Years	2x
Revenue Growth3 Y	1.53x
Revenue Growth5 Y	0.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$1.1B
Cash	$65.6M
Current Assets	$325M
Current Liabilities	$131.2M
Debt	$138.4M
Debt Equity	$0.18
Debt FCF	$18.45
Equity	$782.1M
Interest Coverage	-10.35
Liabilities	$268M
Long Term Assets	$725.1M
Long Term Liabilities	$136.8M
Net Cash	$-72.8M
Net Cash By Market Cap	$-6.22
Net Debt Equity	$0.09
Net Debt FCF	$9.71
Tangible Book Value	$273.4M
Tangible Book Value Per Share	$5.86
WACC	11.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.48
Inventory Turnover	2.56
Net Working Capital	$149.5M
Quick ratio	1.29
Working Capital	$193.8M
Working Capital Turnover	$3.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.92%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-25.51%
1Y total return	106.36%
200-day SMA	16.92
3Y total return	-0.87%
50-day SMA	24.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-28.09%
All Time High	72.96
All Time High Change	-65.75%
All Time High Date	2018-09-05
All Time Low	9.3
All Time Low Change	168.62%
All Time Low Date	2025-08-05
ATR	0.06
Beta	1.57
Beta1y	2.79
Beta2y	1.3
Ch YTD	122.5
High52	25.49
High52 Date	2026-06-01
High52ch	-1.96%
Low52	9.3
Low52 Date	2025-08-05
Low52ch	168.62%
Ma50ch	0.37%
Price vs 200-day SMA	47.72%
RSI	62.1
RSI Monthly	66.54
RSI Weekly	81.68
Sharpe ratio	1.18x
Sortino ratio	3.93
Total Return	-0.92%
Tr YTD	122.5
Tr1m	0.24%
Tr1w	0.08%
Tr3m	1.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$0.17
Earnings EPS Estimate Growth	0
Earnings Revenue Estimate	173,104,000x
Earnings Revenue Estimate Growth	-1.08x
Operating Income	$16.4M
Operating Income Growth	-58.79
Operating Income Growth Q	10.11
Operating Income Growth3 Y	-24.95
Operating Income Growth5 Y	-0.95
Operating margin	2.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,048,930%
Float Percent	98.29%
Net Borrowing	-9,400,000
Shares Insiders	1.66%
Shares Institutions	92.57%
Shares Out	46,847,816
Shares Qo Q	2.37%
Shares Yo Y	0.92%
Short Float	3.8%
Short Ratio	2.05
Short Shares	3.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5M
Adjusted OCF	24,200,000
Average Volume	767,428.5x
Bv Per Share	16.76
CAPEX	$-29.2M
Ch10y	-25.51
Ch1m	0.24
Ch1w	0.08
Ch1y	106.4
Ch3m	1.13
Ch3y	-0.87
Ch5y	-28.09
Ch6m	90.91
Change	0%
Close	24.99
Depreciation Amortization	39,500,000
Earnings Date	2026-08-04
Earnings Time	bmo
EBIT	$-74.5M
EBITDA	$-35M
EPS	$-1.6
F Score	5
FCF	$7.5M
FCF EV Yield	0.6x
FCF Per Share	$0.16
Financing CF	-11,100,000
Fiscal Year End	December
Founded	2,014
Goodwill	394,000,000
Income Tax	$6.1M
Investing CF	-59,200,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	18.75
Ma150ch	33.3%
Ma20	24.93
Ma20ch	0.23%
Net CF	-31,400,000
Next Earnings Date	2026-08-07
Open	0
Optionable	Yes
P FCF Ratio	156.1
P OCF Ratio	31.9
P OCF Ratio SBC	48.38
Ppne	150,500,000
Price Date	2026-07-27
Ptbv Ratio	4.28
Relative Volume	2.7x
Revenue	715,900,000x
SBC By Revenue	1.75x
Share Based Comp	12,500,000
Tax By Revenue	0.85x
Tr6m	90.91%
Us State	Georgia
Z Score	1.2

Avanos Medical, Inc. (AVNS)

Coverage state: Market snapshot only — no published research

Generate the first AVNS analysis

Price

Financial snapshot

Fair-value bridge

Latest news · AVNS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AVNS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AVNS

Frequently asked questions